|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| A61P 7/06 | |||
| C07K 14/71 |
| (11) | Number of the document | 3117829 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16186033.3 |
| Date of filing the European patent application | 2010-08-13 | |
| (97) | Date of publication of the European application | 2017-01-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| PCT/US2009/0046 | 2009-08-13 | WO | |
| 583177 | 2009-08-13 | US | |
| 305901 P | 2010-02-18 | US |
| (72) |
SEEHRA, Jasbir, US
PEARSALL, Robert, Scott, US
KUMAR, Ravindra, US
|
| (73) |
Acceleron Pharma Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS |
| COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS |